Clinical Trials Browser

Phase 1/2 × patritumab deruxtecan × 30 days × Clear all

NCT06469944 2026-04-13

MK-3475-06C

Phase 1/2 Recruiting

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms

NCT06941272 2026-04-13

MK-9999-01C

Phase 1/2 Recruiting

Neoplasms

NCT07286149 2026-04-09

MK-3475-01F

Phase 1/2 Recruiting

Lung Neoplasms

NCT06445972 2026-04-02

MK-3475-06D

Phase 1/2 Recruiting

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms